期刊文献+

动脉粥样硬化发生机制及治疗药物的研究进展 被引量:72

New Progress in Mechanism and Treatment of Atherosclerosis
在线阅读 下载PDF
导出
摘要 动脉粥样硬化是危害人类健康的主要疾病。随着临床与基础研究的发展,对其发生机制已有较新的认识,血管内皮黏附因子成为新的研究焦点。在抗动脉粥样硬化方面,他汀类调脂药及ACEI的确切作用得到充分证实。动脉粥样硬化的防治取得了巨大进步,本文综述了动脉粥样硬化的发生机制及治疗药物新进展。 Atherosclerosis is the major diseases threatening the human health.With the development of research,new understanding of its pathogenesis has been reached.VCAM-1and ICAM-1 became the new focus.The anti-atherosclerotic effect of Statins and ACEI has been fully confirmed.Great advancement in prevention and treatment of atherosclerosis has been made,In this paper,we review the new progress in mechanism and treatment of atherosclerosis.
出处 《首都医科大学学报》 CAS 北大核心 2010年第6期828-833,共6页 Journal of Capital Medical University
关键词 动脉粥样硬化 机制 治疗 药物 atherosclerosis mechanism treatment drugs
作者简介 Corresponding author, E-mail: cjyu1955@ sina. com
  • 相关文献

参考文献46

  • 1Moghadasian M H.Experimental atherosclerosis:a historical overview[J].Life Sci,2002,70:855-865.
  • 2Williams J K,Sukhova G K,Herrington D M,et al.Pravastatin has cholesterol lowering independent effects on the artery wall of atherosclerotic monkeys[J].J Am Coll Cardiol,1998,31:684-691.
  • 3Danesh J,Wheeler J G,Hirschfield G M,et al.C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease[J].N Engl J Med,2004,350:1387-1397.
  • 4Curb J D,Abbott R D,Rodriguez B L,et al.C-reactive protein and the future risk of thromboembolic stroke in healthy men[J].Circulation,2003,107:2016-2020.
  • 5Hansson G K,Zhou X,Tornquist E,et al.The role of adaptive immunity in atherosclerosis[J].Ann N YAcad Sci,2000,902:53-62.
  • 6Ross R.Atherosclerosis-an inflamrnatory disease[J].N Engl J Med,1999,340:115-126.
  • 7Libby P.Inflammation in atherosclerosis[J].Nature,2002,420:868-874.
  • 8Yehuda S,Yaniv S,Dror H.Atherosclerosis as an infections,inflammatory and antoimmune disease[J].Trends in Immunol,2001,22:293-295.
  • 9Biasucci L M,Liuzzo G,Grillo R L,et a1.Elevate levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instabilitv[J].Circulation,1999,99:855-860.
  • 10Kinlay S,Schwartz G G,Olsson A G,et al.High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study[J].Circulation,2003,108:1560-1566.

二级参考文献6

  • 1冯宗忱.动脉粥样硬化——血管壁的慢性炎症[J].中华心血管病杂志,2005,33(5):393-394. 被引量:66
  • 2LiH,Cybulsky MI,Gimbrone MA Jr,et al. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma [J]. Pathol, 1993,143: 1551-1559.
  • 3Anne Hackman,Yasunori Abe. Levels of soluble adhesion in patients with dyslipidemia circulation[J]. 1996,93:1334-1338.
  • 4Cannon CP,Braunwald E,McCabe CH,et al. Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators, intensive versus moderate lipid lowering with statin after acute coronary syndromes[J]. N Engl J Med, 2004,350 : 1495-1504.
  • 5Fang L,Wei H,Mak KH,et al. Marker of low-grade inflammation and soluble cell adhension molecules in Chinese patients with coronary artery disease[J]. Cardiol,2004,20(14) :1433-1438.
  • 6Funatsn T,Kakuta H ,Tanaka H,et al. Atorvastatin(lipitor);a review of its pharmacological and clinical profile[J]. Nippon Yakurigaku Zasshi, 2001,117 ( 1 ): 65-69.

共引文献4

同被引文献998

引证文献72

二级引证文献673

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部